BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

CeloNova BioSciences 

18615 Tuscany Stone
Suite 100
San Antonio   Texas  78258  U.S.A.
Phone: 210-489-4000 Fax: 210-403-2008


SEARCH JOBS




Industry
Medical Device






 Company News
GRCI 2014 Update: CeloNova BioSciences' COBRA Pzf™ Coronary Stent Achieves A Low 3% TLR With Short DAPT 12/12/2014 8:19:12 AM
CeloNova BioSciences's Super-Selective Embolic Microsphere With Drug Loading Capabilities Could Mean Improved Quality Of Life And Overall Survival For Liver Cancer Patients 10/30/2014 10:35:05 AM
CeloNova BioSciences Release: First-In-Man Study Of The COBRA PzF™ Coronary Stent Shows Promising Results Highlighted By Short, 30-Day Dual-Antiplatelet Therapy And Low, 3% TLR Rate 9/16/2014 8:52:12 AM
CeloNova BioSciences Receives Expanded Indication in Liver Cancer 9/3/2014 11:09:38 AM
CeloNova BioSciences’s Coronary Stent System Could Mean Faster Healing Of Arteries And Greatly Reduced Use Of Blood-Thinning Medication 3/18/2014 9:33:13 AM
CeloNova BioSciences Release: New Treatment Option For Women An Alternative To Hysterectomy 3/11/2014 9:05:45 AM
CeloNova BioSciences: Dr. Barry Katzen to Present CATANIA(TM) Coronary Stent Data in Tel Aviv 12/2/2009 8:28:24 AM
CeloNova BioSciences: Minimally Invasive Device Approved to Treat Liver Cancer, Fibroids, Tumors, and Bleeding 10/14/2009 8:59:35 AM
CeloNova BioSciences: Scientific Paper Supports Micro-Bland Embolization Technique for Liver Cancer With Embozene(TM) Microspheres 10/6/2009 10:52:37 AM
New Embolization Technique Using CeloNova BioSciences's Embozene(TM) Color-Advanced Microspheres Offers Better Clinical Outcomes In The Treatment Of Liver Cancer, European Institute of Oncology (EIO) Study 10/6/2009 7:50:52 AM
123